1613148-62-1

Basic information

• Product Name: 3-(1-(2,6-dichlorophenyl)ethoxy)-2-nitropyridine
• Synonyms: 3-(1-(2,6-dichlorophenyl)ethoxy)-2-nitropyridine
• CAS NO: 1613148-62-1
• Molecular Weight: 313.14
• Mol File: 1613148-62-1.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 3-(1-(2,6-dichlorophenyl)ethoxy)-2-nitropyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(1-(2,6-dichlorophenyl)ethoxy)-2-nitropyridine(1613148-62-1)
• EPA Substance Registry System: 3-(1-(2,6-dichlorophenyl)ethoxy)-2-nitropyridine(1613148-62-1)

Safety Data

• Hazardous Substances Data: 1613148-62-1(Hazardous Substances Data)

Upstream product

• 54231-35-5 3-fuoro-2-nitropyridine 
• 53066-19-6 1-(2',6'-dichlorophenyl)-ethanol 
• 15128-82-2 3-hydroxy-2-nitropyridine 

Downstream Products

• 1613148-63-2 3-(1-(2,6-dichlorophenyl)ethoxy)pyridin-2-amine 
• 756520-82-8 5-bromo-3-(1-(2,6-dichlorophenyl)ethoxy)pyridin-2-amine 
• 1613148-64-3 5-bromo-N,N-bis(tert-butoxycarbonyl)-3-(1-(2,6-dichlorophenyl)ethoxy)pyridin-2-amine 
• 1613148-65-4 N,N-bis(tert-butoxycarbonyl)-3-(1-(2,6-dichlorophenyl)ethoxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine 
• 1613148-66-5 3-(6-(bis(tert-butoxycarbonyl)amino)-5-(1-(2,6-dichlorophenyl)ethoxy)pyridin-3-yl)-6-(tert-butoxycarbonyl)-5,6,7,8-tetrahydro-1,6-naphthyridin-8-ol 
• 1613148-61-0 3-(6-amino-5-(1-(2,6-dichlorophenyl)ethoxy)pyridin-3-yl)-5,6,7,8-tetrahydro-1, 6-naphthyridin-8-ol 

Relevant articles and documents

SELECTIVE JAK2 INHIBITOR AND APPLICATION THEREOF

Provided is a selective JAK2 inhibitor and application thereof. In particular, it relates to the compound of the following Formula (I), and the use of the compound in the treatment of JAK2-mediated related diseases and in the preparation of the medicament for treating JAK2-mediated related diseases.

Substituted ring compound and its method and use thereof

The invention provides a substituted cyclic compound as well as a use method and application thereof. The compound is a compound as shown in a formula (I) or stereoisomers, stereomers, tautomers, nitric oxides, solvates, metabolites and pharmaceutically acceptable salts or prodrugs of the compound as shown in the formula (I). The invention further provides a medicament composition containing the compound. The compound and the medicament composition are capable of regulating the activity of protein kinase in a biological sample body and are used for protecting, treating or relieving proliferative diseases of patients. The formula (I) is as shown in the specification.